Prelude Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-13,156
| Closed | -$71.7K | – | 977 |
|
|
2023
Q3 | $71.7K | Sell |
13,156
-18,648
| -59% | -$102K | ﹤0.01% | 874 |
|
|
2023
Q2 | $213K | Sell |
31,804
-3,650
| -10% | -$24.5K | 0.01% | 710 |
|
|
2023
Q1 | $313K | Buy |
35,454
+12,776
| +56% | +$113K | 0.02% | 557 |
|
|
2022
Q4 | $173K | Sell |
22,678
-80,138
| -78% | -$612K | 0.01% | 865 |
|
|
2022
Q3 | $732K | Buy |
102,816
+8,591
| +9% | +$61.2K | 0.03% | 506 |
|
|
2022
Q2 | $762K | Sell |
94,225
-50,957
| -35% | -$412K | 0.02% | 512 |
|
|
2022
Q1 | $2.02M | Buy |
+145,182
| New | +$2.02M | 0.06% | 250 |
|
|
2021
Q4 | – | Sell |
-6,489
| Closed | -$221K | – | 1580 |
|
|
2021
Q3 | $221K | Sell |
6,489
-1,361
| -17% | -$46.4K | 0.01% | 983 |
|
|
2021
Q2 | $321K | Sell |
7,850
-13,043
| -62% | -$533K | 0.01% | 937 |
|
|
2021
Q1 | $841K | Buy |
20,893
+15,781
| +309% | +$635K | 0.02% | 411 |
|
|
2020
Q4 | $302K | Buy |
5,112
+3,745
| +274% | +$221K | 0.01% | 514 |
|
|
2020
Q3 | $66K | Buy |
+1,367
| New | +$66K | ﹤0.01% | 795 |
|
|
2019
Q4 | – | Sell |
-143
| Closed | -$4K | – | 1375 |
|
|
2019
Q3 | $4K | Buy |
+143
| New | +$4K | ﹤0.01% | 1078 |
|